Cargando…

A Longitudinal Cohort Study of Emergency Room Utilization Following Mifepristone Chemical and Surgical Abortions, 1999–2015

INTRODUCTION: Existing research on postabortion emergency room visits is sparse and limited by methods which underestimate the incidence of adverse events following abortion. Postabortion emergency room (ER) use since Food and Drug Administration approval of chemical abortion in 2000 can identify tr...

Descripción completa

Detalles Bibliográficos
Autores principales: Studnicki, James, Harrison, Donna J., Longbons, Tessa, Skop, Ingrid, Reardon, David C., Fisher, John W., Tsulukidze, Maka, Craver, Christopher
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581786/
https://www.ncbi.nlm.nih.gov/pubmed/34778493
http://dx.doi.org/10.1177/23333928211053965
_version_ 1784596880265576448
author Studnicki, James
Harrison, Donna J.
Longbons, Tessa
Skop, Ingrid
Reardon, David C.
Fisher, John W.
Tsulukidze, Maka
Craver, Christopher
author_facet Studnicki, James
Harrison, Donna J.
Longbons, Tessa
Skop, Ingrid
Reardon, David C.
Fisher, John W.
Tsulukidze, Maka
Craver, Christopher
author_sort Studnicki, James
collection PubMed
description INTRODUCTION: Existing research on postabortion emergency room visits is sparse and limited by methods which underestimate the incidence of adverse events following abortion. Postabortion emergency room (ER) use since Food and Drug Administration approval of chemical abortion in 2000 can identify trends in the relative morbidity burden of chemical versus surgical procedures. OBJECTIVE: To complete the first longitudinal cohort study of postabortion emergency room use following chemical and surgical abortions. METHODS: A population-based longitudinal cohort study of 423 000 confirmed induced abortions and 121,283 subsequent ER visits occurring within 30 days of the procedure, in the years 1999-2015, to Medicaid-eligible women over 13 years of age with at least one pregnancy outcome, in the 17 states which provided public funding for abortion. RESULTS: ER visits are at greater risk to occur following a chemical rather than a surgical abortion: all ER visits (OR 1.22, CL 1.19-1.24); miscoded spontaneous (OR 1.88, CL 1.81-1.96); and abortion-related (OR 1.53, CL 1.49-1.58). ER visit rates per 1000 abortions grew faster for chemical abortions, and by 2015, chemical versus surgical rates were 354.8 versus 357.9 for all ER visits; 31.5 versus 8.6 for miscoded spontaneous abortion visits; and 51.7 versus 22.0 for abortion-related visits. Abortion-related visits as a percent of total visits are twice as high for chemical abortions, reaching 14.6% by 2015. Miscoded spontaneous abortion visits as a percent of total visits are nearly 4 times as high for chemical abortions, reaching 8.9% of total visits and 60.9% of abortion-related visits by 2015. CONCLUSION: The incidence and per-abortion rate of ER visits following any induced abortion are growing, but chemical abortion is consistently and progressively associated with more postabortion ER visit morbidity than surgical abortion. There is also a distinct trend of a growing number of women miscoded as receiving treatment for spontaneous abortion in the ER following a chemical abortion.
format Online
Article
Text
id pubmed-8581786
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-85817862021-11-12 A Longitudinal Cohort Study of Emergency Room Utilization Following Mifepristone Chemical and Surgical Abortions, 1999–2015 Studnicki, James Harrison, Donna J. Longbons, Tessa Skop, Ingrid Reardon, David C. Fisher, John W. Tsulukidze, Maka Craver, Christopher Health Serv Res Manag Epidemiol Original Research INTRODUCTION: Existing research on postabortion emergency room visits is sparse and limited by methods which underestimate the incidence of adverse events following abortion. Postabortion emergency room (ER) use since Food and Drug Administration approval of chemical abortion in 2000 can identify trends in the relative morbidity burden of chemical versus surgical procedures. OBJECTIVE: To complete the first longitudinal cohort study of postabortion emergency room use following chemical and surgical abortions. METHODS: A population-based longitudinal cohort study of 423 000 confirmed induced abortions and 121,283 subsequent ER visits occurring within 30 days of the procedure, in the years 1999-2015, to Medicaid-eligible women over 13 years of age with at least one pregnancy outcome, in the 17 states which provided public funding for abortion. RESULTS: ER visits are at greater risk to occur following a chemical rather than a surgical abortion: all ER visits (OR 1.22, CL 1.19-1.24); miscoded spontaneous (OR 1.88, CL 1.81-1.96); and abortion-related (OR 1.53, CL 1.49-1.58). ER visit rates per 1000 abortions grew faster for chemical abortions, and by 2015, chemical versus surgical rates were 354.8 versus 357.9 for all ER visits; 31.5 versus 8.6 for miscoded spontaneous abortion visits; and 51.7 versus 22.0 for abortion-related visits. Abortion-related visits as a percent of total visits are twice as high for chemical abortions, reaching 14.6% by 2015. Miscoded spontaneous abortion visits as a percent of total visits are nearly 4 times as high for chemical abortions, reaching 8.9% of total visits and 60.9% of abortion-related visits by 2015. CONCLUSION: The incidence and per-abortion rate of ER visits following any induced abortion are growing, but chemical abortion is consistently and progressively associated with more postabortion ER visit morbidity than surgical abortion. There is also a distinct trend of a growing number of women miscoded as receiving treatment for spontaneous abortion in the ER following a chemical abortion. SAGE Publications 2021-11-09 /pmc/articles/PMC8581786/ /pubmed/34778493 http://dx.doi.org/10.1177/23333928211053965 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (https://creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access page (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Original Research
Studnicki, James
Harrison, Donna J.
Longbons, Tessa
Skop, Ingrid
Reardon, David C.
Fisher, John W.
Tsulukidze, Maka
Craver, Christopher
A Longitudinal Cohort Study of Emergency Room Utilization Following Mifepristone Chemical and Surgical Abortions, 1999–2015
title A Longitudinal Cohort Study of Emergency Room Utilization Following Mifepristone Chemical and Surgical Abortions, 1999–2015
title_full A Longitudinal Cohort Study of Emergency Room Utilization Following Mifepristone Chemical and Surgical Abortions, 1999–2015
title_fullStr A Longitudinal Cohort Study of Emergency Room Utilization Following Mifepristone Chemical and Surgical Abortions, 1999–2015
title_full_unstemmed A Longitudinal Cohort Study of Emergency Room Utilization Following Mifepristone Chemical and Surgical Abortions, 1999–2015
title_short A Longitudinal Cohort Study of Emergency Room Utilization Following Mifepristone Chemical and Surgical Abortions, 1999–2015
title_sort longitudinal cohort study of emergency room utilization following mifepristone chemical and surgical abortions, 1999–2015
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8581786/
https://www.ncbi.nlm.nih.gov/pubmed/34778493
http://dx.doi.org/10.1177/23333928211053965
work_keys_str_mv AT studnickijames alongitudinalcohortstudyofemergencyroomutilizationfollowingmifepristonechemicalandsurgicalabortions19992015
AT harrisondonnaj alongitudinalcohortstudyofemergencyroomutilizationfollowingmifepristonechemicalandsurgicalabortions19992015
AT longbonstessa alongitudinalcohortstudyofemergencyroomutilizationfollowingmifepristonechemicalandsurgicalabortions19992015
AT skopingrid alongitudinalcohortstudyofemergencyroomutilizationfollowingmifepristonechemicalandsurgicalabortions19992015
AT reardondavidc alongitudinalcohortstudyofemergencyroomutilizationfollowingmifepristonechemicalandsurgicalabortions19992015
AT fisherjohnw alongitudinalcohortstudyofemergencyroomutilizationfollowingmifepristonechemicalandsurgicalabortions19992015
AT tsulukidzemaka alongitudinalcohortstudyofemergencyroomutilizationfollowingmifepristonechemicalandsurgicalabortions19992015
AT craverchristopher alongitudinalcohortstudyofemergencyroomutilizationfollowingmifepristonechemicalandsurgicalabortions19992015
AT studnickijames longitudinalcohortstudyofemergencyroomutilizationfollowingmifepristonechemicalandsurgicalabortions19992015
AT harrisondonnaj longitudinalcohortstudyofemergencyroomutilizationfollowingmifepristonechemicalandsurgicalabortions19992015
AT longbonstessa longitudinalcohortstudyofemergencyroomutilizationfollowingmifepristonechemicalandsurgicalabortions19992015
AT skopingrid longitudinalcohortstudyofemergencyroomutilizationfollowingmifepristonechemicalandsurgicalabortions19992015
AT reardondavidc longitudinalcohortstudyofemergencyroomutilizationfollowingmifepristonechemicalandsurgicalabortions19992015
AT fisherjohnw longitudinalcohortstudyofemergencyroomutilizationfollowingmifepristonechemicalandsurgicalabortions19992015
AT tsulukidzemaka longitudinalcohortstudyofemergencyroomutilizationfollowingmifepristonechemicalandsurgicalabortions19992015
AT craverchristopher longitudinalcohortstudyofemergencyroomutilizationfollowingmifepristonechemicalandsurgicalabortions19992015